UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Current state of Alzheimer’s fluid biomarkers

Acta neuropathologica, 2018-12, Vol.136 (6), p.821-853

2018

Link zum Volltext

Verfügbarkeit prüfen

Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations

Journal of Parkinson's disease, 2021-01, Vol.11 (s2), p.S183

2021

Link zum Volltext

Verfügbarkeit prüfen

Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial

American journal of Alzheimer's disease and other dementias, 2010-03, Vol.25 (2), p.119

2010

Link zum Volltext

Verfügbarkeit prüfen

Early risk assessment for Alzheimer's disease

Alzheimer's & dementia, 2009-03, Vol.5 (2), p.182-196

2009

Link zum Volltext

Verfügbarkeit prüfen

Design and outcome measures for a phase 1/2 dose-finding study to evaluate systemic administration of an AAV9-based gene therapy for peripheral manifestations of Gaucher disease

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107239, Article 107239

2023

Link zum Volltext

Verfügbarkeit prüfen

Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial)

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial): Human/Trial design

Alzheimer's & dementia, 2020-12, Vol.16 (S9)

2020

Link zum Volltext

Verfügbarkeit prüfen

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD

Neurology, 2017-12, Vol.89 (24), p.2495

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase 1/2 study update of an AAV9-based gene therapy for Gaucher disease type 2 (PROVIDE trial)

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107238, Article 107238

2023

Link zum Volltext

Verfügbarkeit prüfen

HIV encephalitis simulating Huntington's disease

Movement disorders, 2005-05, Vol.20 (5), p.610-613

2005

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy for Alzheimer's disease: Are we ready?

Alzheimer's & dementia, 2018-09, Vol.14 (9), p.1232-1233

2018

Link zum Volltext

Verfügbarkeit prüfen

S43. A PROOF-OF-MECHANISM STUDY OF THE PDE10 INHIBITOR RG7203 IN PATIENTS WITH PROBING REWARD FUNCTIONS WITH IMAGING AND BEHAVIORAL APPROACHES

Schizophrenia bulletin, 2018-04, Vol.44 (suppl_1), p.S340-S341

2018

Link zum Volltext

Verfügbarkeit prüfen

P1–359: A single ascending‐dose study of BIIB037 in people with mild‐to‐moderate Alzheimer's disease

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_7), p.P290-P290

2013

Link zum Volltext

Verfügbarkeit prüfen

A single ascending-dose study of BIIB037 in people with mild-to-moderate Alzheimer's disease

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P290-P290

2013

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection

Archives of neurology (Chicago), 2007-01, Vol.64 (1), p.97

2007

Link zum Volltext

Verfügbarkeit prüfen

P3‐275: Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_17), p.S532-S532

2010

Link zum Volltext

Verfügbarkeit prüfen

Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S532-S532

2010

Link zum Volltext

Verfügbarkeit prüfen

Meeting Report: Early risk assessment for Alzheimer's disease

Alzheimer's & dementia, 2009-03, Vol.5 (2), p.182-196

2009

Link zum Volltext

Verfügbarkeit prüfen

21 - Infections of the Central Nervous System

On Call Neurology, p.294-314

Sevigny, Jeffrey Joseph

Link zum Volltext

Verfügbarkeit prüfen

Evolution of epidemiologic methods and concepts in selected textbooks of the 20th century

Sozial- und Präventivmedizin, 2004, Vol.49 (2), p.97

2004

Link zum Volltext

Verfügbarkeit prüfen

Axial MRI biomarkers of spinal cord damage to predict future walking and motor function: a retrospective study

Spinal cord, 2021-06, Vol.59 (6), p.693-699

2021

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolism: Exploring Incidence and Utility of Screening in Individuals With Brain Injury

Archives of physical medicine and rehabilitation, 2023-07, Vol.104 (7), p.1035-1040

2023

Link zum Volltext

Verfügbarkeit prüfen

Biodiversity estimates and ecological interpretations of meiofaunal communities are biased by the taxonomic approach

Communications biology, 2018-01, Vol.1 (1), p.112, Article 112

2018

Link zum Volltext

Verfügbarkeit prüfen

Linking scores on the 4- and 5-item versions of the Satisfaction with Life Scale in people with traumatic brain, spinal cord, or burn injury: a National Institute on Disability, Independent Living, and Rehabilitation Research Model System study

Journal of patient-reported outcomes, 2021-07, Vol.5 (1), p.59-59, Article 59

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(37)
Buchkapitel
(1)

Sprache

Englisch
(38)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Current state of Alzheimer’s fluid biomarkers

Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations

Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial

Early risk assessment for Alzheimer's disease

Design and outcome measures for a phase 1/2 dose-finding study to evaluate systemic administration of an AAV9-based gene therapy for peripheral manifestations of Gaucher disease

Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial)

Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial): Human/Trial design

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD

Phase 1/2 study update of an AAV9-based gene therapy for Gaucher disease type 2 (PROVIDE trial)

HIV encephalitis simulating Huntington's disease

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

Combination therapy for Alzheimer's disease: Are we ready?

S43. A PROOF-OF-MECHANISM STUDY OF THE PDE10 INHIBITOR RG7203 IN PATIENTS WITH PROBING REWARD FUNCTIONS WITH IMAGING AND BEHAVIORAL APPROACHES

P1–359: A single ascending‐dose study of BIIB037 in people with mild‐to‐moderate Alzheimer's disease

A single ascending-dose study of BIIB037 in people with mild-to-moderate Alzheimer's disease

An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection

P3‐275: Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients

Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients

Meeting Report: Early risk assessment for Alzheimer's disease

21 - Infections of the Central Nervous System

Evolution of epidemiologic methods and concepts in selected textbooks of the 20th century

Axial MRI biomarkers of spinal cord damage to predict future walking and motor function: a retrospective study

Venous Thromboembolism: Exploring Incidence and Utility of Screening in Individuals With Brain Injury

Biodiversity estimates and ecological interpretations of meiofaunal communities are biased by the taxonomic approach

Linking scores on the 4- and 5-item versions of the Satisfaction with Life Scale in people with traumatic brain, spinal cord, or burn injury: a National Institute on Disability, Independent Living, and Rehabilitation Research Model System study

Suchergebnisse filtern